Pluri (PLUR) Receivables - Other (2010 - 2024)
Pluri's (PLUR) quarterly Receivables - Other came in at $10000.0 in Q2 2024, down 73.68% year-over-year from $38000.0 in Q3 2023, and down 73.68% quarter-over-quarter from $38000.0 in Q2 2023.
Powered by 
Analysis
Pluri (PLUR) Receivables - Other (2010 - 2024) Analysis & Trends
Pluri (PLUR) has reported Receivables - Other for 15 consecutive years, with $10000.0 the latest figure, recorded in Q2 2024.
- On a quarterly basis, Receivables - Other fell 73.68% year-over-year to $10000.0 in Q2 2024; TTM through Jun 2024 was $10000.0, a 73.68% decrease from a year earlier, with the FY2024 full-year figure at $10000.0, down 73.68% from the prior year.
- Receivables - Other was $10000.0 for Q2 2024 at Pluri, down from $38000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $87000.0 in Q2 2020 and troughed at -$142000.0 in Q3 2020.
- A 5-year average of $29230.8 and a median of $52000.0 in 2021 frame the typical range for Receivables - Other.
- The widest YoY moves for Receivables - Other: up 182.08% in 2020, down 99.51% in 2020.
- Over 5 years, Receivables - Other stood at -$142000.0 in 2020, then surged by 136.62% to $52000.0 in 2021, then changed by 0.0% to $52000.0 in 2022, then decreased by 26.92% to $38000.0 in 2023, then tumbled by 73.68% to $10000.0 in 2024.
- The last three Receivables - Other figures came in at $10000.0 (Q2 2024), $38000.0 (Q2 2023), and $52000.0 (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | Pluri | 13.57 Mn | 6.48 Mn | 86,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | 52,000.00 |
| Dec 31, 2021 | 52,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Sep 30, 2020 | -142,000.00 |
| Jun 30, 2020 | 87,000.00 |
| Mar 31, 2020 | 1,000.00 |
| Dec 31, 2019 | -17,000.00 |
| Sep 30, 2019 | -108,000.00 |
| Jun 30, 2019 | -106,000.00 |
| Mar 31, 2019 | 203,000.00 |
| Dec 31, 2018 | 45,000.00 |
| Sep 30, 2018 | -21,000.00 |
| Jun 30, 2018 | -538,000.00 |